October 5, 2007 â Handling with tadalafil in men with erectile dysfunction after radiotherapy for prostatic carcinoma was effective and well tolerated, according to the results of a bailiwick reported in the October printing of the International Written material of Action Oncology, Assemblage and Natural philosophy.
"Erectile dysfunction after three-dimensional conformal external-beam radiotherapy (3DCRT) for prostatic carcinoma is reported in as many as 64% of those patients," write Luca Incrocci, MD, PhD, from the Erasmus MC-Daniel den Hoed Malignant neoplasm Centre in Rotterdam, the Netherlands, and colleagues. "The end of this memorizer was to determine the efficacy of the oral drug tadalafil soft tablets 20mg (Cialis) in patients with erectile dysfunction after radiotherapy for prostatic carcinoma."
Friday, November 23, 2007
Erectile Dysfunction in Men With Prostatic Carcinoma
Subscribe to:
Post Comments (Atom)
Blog Archive
-
▼
2007
(12)
-
▼
November
(8)
- For The Medical building.
- Rimonabant: Endocannabinoid Inhibition for the Met...
- Erectile Dysfunction in Men With Prostatic Carcinoma
- The subject field was funded by Sanofi-Aventis.
- This offers a new golf stroke.
- Rimonabant Reduces Lipids, Weight, and Adiposity.
- This represents a subject field medical shift.
- Rimonabant has been called the anti-marijuana.
-
▼
November
(8)
No comments:
Post a Comment